Data / Form D filings / Nula Therapeutics, Inc.
Nula Therapeutics, Inc.: Form D filing
Nula Therapeutics, Inc., a biotechnology company in St. Petersburg, FL, filed a Form D with the SEC in 2026. The latest, on March 18, 2026, reports $7.4 million sold of a $7.4 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 961 Arlington Ave N, St. Petersburg, FL, 33705
- Phone
- (212) 392-4735
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2121301
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | New notice | $7,399,003 | $7,399,003 | 7 | Feb 17, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Shepard | Executive Officer, Director | |
| Jarod Rutledge | Director | |
| Nils Regge | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Mar 16, 2026 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Nula Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.